Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 3, 2009, Pages 297-300

  Coskun, Murat ^a,b   Zoroglu, Salih ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HYDROXYZINE; RISPERIDONE;

ABDOMINAL PAIN; AGGRESSION; ARTICLE; AUTOMUTILATION; BEHAVIOR DISORDER; BEHAVIORAL DISINHIBITION; BRUXISM; CHILD; CLINICAL ARTICLE; DECREASED APPETITE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXCESSIVE TALKING; FATIGUE; FEMALE; HEADACHE; HIGH RISK BEHAVIOR; HUMAN; HYPERACTIVITY; IRRITABILITY; MALE; NIGHTMARE; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL BEHAVIOR; PRESCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; SYMPTOM; TALKING WITH UNFAMILIAR PEOPLE; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION;

ANTIPSYCHOTIC AGENTS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOXETINE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; RISPERIDONE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 67650872580     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.055     Document Type: Article

References (10)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSMIV- TR). Washington (DC): American Psychiatric Association, 2000.
2. Egger HL, Angold A: Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology.J Child Psychol Psychiatry 47:313-337, 2006.
3. Geller DA, Biederman J, Reed ED, Spencer T, Wilens TE. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J AmAcad Child Adolesc Psychiatry 34:36-44, 1995.
4. Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Team: Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 40: 773-779, 2001.
5. Gleason MM, Egger HL, Emsile GJ, Greenhill LL, Kowatch RA, Lieberman AF, Luby JL, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah CH: Psychopharmacological treatment for very young children: Contexts and guidelines J. Am. Acad. Child Adolesc. Psychiatry 46:1532-1572, 2007.
6. Hollingsworth CE, Tanguay PE, Grossman L, Pabst P: Longterm outcome of obsessive-compulsive disorder in childhood.J Am Acad Child Adolesc Psychiatry 19:134-44, 1980.
7. Leonard HL, Goldberger EL, Rapoport JL, Cheslow DL, Swedo SE. Childhood rituals: Normal developmental or obsessivecompulsive symptoms? J Am Acad Child Adolesc Psychiatry29:17-23, 1990.
8. Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB: Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. J. Am. Acad. Child AdolescPsychiatry 41:1431-1438, 2002.
9. Swedo SE, Rapoport JL, Leonard H, Lenane M, Cheslow D: Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch GenPsychiatry 46:335-341, 1989.
10. Zuckerman ML, Vaughan BL, Whitney J, Dodds A, Yakhkind A, MacMillan C, Raches D, Pravdova I, DeMaso DR, Beardslee WR, Heydrich JG: Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: A retrospective chart review. J Child Adolesc Psychopharmacol17:165-174, 2007.